Duke University School of Medicine researchers have unveiled Raygun, an artificial intelligence framework that can redesign proteins at a scale reminiscent of natural evolution. Unlike...
A July 20, 2026 review in Immunity & Inflammation reframes microbiome science by proposing a hidden population: persistent intracellular extraintestinal microbes, or PIEMs. Led by...
Intrinsically disordered proteins (IDRs)—segments that do not adopt a single stable 3D structure—are common across life and perform crucial cellular jobs. Yet while scientists can...
A recent study adds a new piece to the emerging map of ACE2 biology—an essential entry point exploited by SARS‑CoV‑2 for infection. Researchers report that...
New evidence links a failure of cellular cleanup to the distinctive brain damage of Alzheimer’s disease. In a study in Nature Neuroscience, researchers used an...
A new study adds weight to a growing idea: the gut microbiome doesn’t just digest food—it can actively regulate how the body stores and absorbs...
A new viral-science report spotlights how a pair of neuronal ion pumps—neuronal Na⁺,K⁺-ATPase isoforms—switch between distinct active shapes, and how one disease-associated mutant disrupts that...
Emergency departments facing bronchiolitis in infants often rely on high-flow nasal cannula (HFNC) oxygen therapy, a tool that can help when respiratory distress escalates. Yet...
Premature infants undergoing retinopathy of prematurity (ROP) screening can experience repeated stress responses during examinations—an issue that matters because even brief discomfort may amplify physiological...
Multiple myeloma (MM) treatment is entering a “de-escalation” era: clinicians aim to preserve deep, durable disease control while lowering long-term toxicity and treatment burden. As...
Scientists are racing to mimic photosynthesis by turning carbon dioxide (CO₂) into fuels and chemicals using sunlight. A major bottleneck in photocatalysis is finding materials...
Atomically thin electronics are inching toward a breakthrough—and the bottleneck is not the channel, but the contact. In graphene and transition metal dichalcogenides (TMDs), the...
Insilico Medicine has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ISM6331, an investigational pan-TEAD inhibitor being developed...
ST. LOUIS—The American College of Lifestyle Medicine (ACLM) has launched Project Remission, a new initiative urging healthcare systems to rethink chronic disease goals. Rather than...
A new study suggests that two inherited cardiomyopathies—dilated cardiomyopathy (DCM) and left ventricular non-compaction (LVNC)—can diverge dramatically from an almost identical genetic change. The work,...
